IL-1β Impaired Diabetic Wound Healing by Regulating MMP-2 and MMP-9 through the p38 Pathway

Local Administration of Interleukin-1 Receptor Antagonist Improves Diabetic Wound Healing

(2018) David P. Perrault et al.   ANNALS OF PLASTIC SURGERY

NLRP3 Inflammasome Expression and Signaling in Human Diabetic Wounds and in High Glucose Induced Macrophages

(2017) Xiaotian Zhang et al.   Journal of Diabetes Research

Growth Differentiation Factor-9 Promotes Fibroblast Proliferation and Migration in Keloids through the Smad2/3 Pathway

(2016) Zhaohua Jiang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Prevention and Care Programs Addressing the Growing Prevalence of Diabetes in China

(2016) Junmei Yin et al.   Current Diabetes Reports

Src promotes cutaneous wound healing by regulating MMP-2 through the ERK pathway

(2016) XUE WU et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Wound Healing and Skin Regeneration

(2015) M. Takeo et al.   Cold Spring Harbor Perspectives in Medicine

IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9

(2014) Qiaojia Huang et al.   Molecular Cancer

Blocking Interleukin-1  Induces a Healing-Associated Wound Macrophage Phenotype and Improves Healing in Type 2 Diabetes

(2013) R. E. Mirza et al.   DIABETES

Global estimates of diabetes prevalence for 2013 and projections for 2035

(2013) L. Guariguata et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Interleukin-1 antagonists for diabetes

(2013) Thomas Mandrup-Poulsen   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing

(2013) Nicholas S. Greaves et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Adult Zebrafish as a Model System for Cutaneous Wound-Healing Research

(2013) Rebecca Richardson et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Interleukin-1 (IL-1) family of cytokines: Role in Type 2 Diabetes

(2012) Monisha Banerjee et al.   CLINICA CHIMICA ACTA

p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells

(2012) Yiu To Yeung et al.   JOURNAL OF NEURO-ONCOLOGY

Interleukin-1 Receptor Antagonist: A New Therapy for Type 2 Diabetes Mellitus

(2012) Muhammad Sajid Hamid Akash et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Toll-like receptors, the NLRP3 inflammasome and interleukin-1β in the development and progression of type 1 diabetes

(2012) Ellen K. Grishman et al.   PEDIATRIC RESEARCH

Skin Regeneration in Adult Axolotls: A Blueprint for Scar-Free Healing in Vertebrates

(2012) Ashley W. Seifert et al.   PLoS One

Blockade of interleukin 1 in type 1 diabetes mellitus

(2010) Thomas Mandrup-Poulsen et al.   Nature Reviews Endocrinology

The role of interleukins in insulin resistance and type 2 diabetes mellitus

(2009) Bruno Fève et al.   Nature Reviews Endocrinology

Increased Interleukin (IL)-1β Messenger Ribonucleic Acid Expression in β-Cells of Individuals with Type 2 Diabetes and Regulation of IL-1β in Human Islets by Glucose and Autostimulation

(2008) Marianne Böni-Schnetzler et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Interleukin-1β and tumor necrosis factor-α have opposite effects on fibroblasts and epithelial cells during basement membrane formation

(2008) Akiko Furuyama et al.   MATRIX BIOLOGY

PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing

(2008) Stephan Barrientos et al.   WOUND REPAIR AND REGENERATION